FDA Approved: SUFENTANIL CITRATE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for sufentanil citrate from Hospira, Inc., under ANDA074534.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Postoperative Pain

Drugs mentioned

• SUFENTANIL CITRATE (SUFENTANIL CITRATE)

Snippet

SUPPL AP for SUFENTANIL CITRATE (SUFENTANIL CITRATE)